2017
DOI: 10.1371/journal.pone.0181246
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric cancer risk in association with birth defects: A systematic review

Abstract: BackgroundMany epidemiological studies have examined associations between birth defects (BDs) and pediatric malignancy over the past several decades. Our objective was to conduct a systematic literature review of studies reporting on this association.MethodsWe used librarian-designed searches of the PubMed Medline and Embase databases to identify primary research articles on pediatric neoplasms and BDs. English language articles from PubMed and Embase up to 10/12/2015, and in PubMed up to 5/12/2017 following a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
53
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 45 publications
(62 citation statements)
references
References 92 publications
8
53
1
Order By: Relevance
“…More than 80 studies have reported an association between birth defects and cancer, based on a variety of study designs, sample sizes, and data sources. 10 The 2.07-fold increase in cancer risk among children with major nonchromosomal birth defects in the fertile group that we report is consistent with the other US population-based cohort studies that linked to state birth defect and cancer registries, with increases ranging from 1.58-fold 11 to 2.0-fold 12 , 2.5-fold, 13 , 14 to 2.86-fold. 15 The finding of a 15.45-fold cancer risk among children with chromosomal birth defects in the fertile group is also consistent with the point estimates and 95% CIs of previous reports, ranging from 11.6 (95% CI, 10.4-12.9) to 15.52 (95% CI, 11.66-20.27).…”
Section: Discussionsupporting
confidence: 90%
“…More than 80 studies have reported an association between birth defects and cancer, based on a variety of study designs, sample sizes, and data sources. 10 The 2.07-fold increase in cancer risk among children with major nonchromosomal birth defects in the fertile group that we report is consistent with the other US population-based cohort studies that linked to state birth defect and cancer registries, with increases ranging from 1.58-fold 11 to 2.0-fold 12 , 2.5-fold, 13 , 14 to 2.86-fold. 15 The finding of a 15.45-fold cancer risk among children with chromosomal birth defects in the fertile group is also consistent with the point estimates and 95% CIs of previous reports, ranging from 11.6 (95% CI, 10.4-12.9) to 15.52 (95% CI, 11.66-20.27).…”
Section: Discussionsupporting
confidence: 90%
“…The present findings of a consistent, increased incidence among males for all ages combined and by single year of age for cancer overall and most tumor types suggest that sex, and the associated biologic properties, may underlie the male excess in childhood cancer incidence. Some sex disparities in childhood cancer incidence may be due to the male excess in birth defects (overall male:female ratio 1.18; 95% CI, 1.13–1.24) and chromosomal abnormalities such as Down syndrome, which are associated with an increased risk of childhood cancer and leukemia, respectively. Other biologic mechanisms for the increased risk of childhood cancer among males may depend on sex differences in (1) germline variation and gene expression on the X and autosomal chromosomes; (2) immune responses; and (3) pubertal hormone profiles and the corresponding growth rates …”
Section: Discussionmentioning
confidence: 99%
“…We conducted analyses for only those cancers with at least 5 cases diagnosed among each age group. Because of the documented association between certain childhood cancers and chromosomal anomalies or single gene disorders, which are generally independent of sex ( 9 , 22–24 ), we conducted subgroup analyses excluding children with chromosomal anomalies (n = 22 420), or single gene disorders (neurofibromatosis type I and tuberous sclerosis) (n = 2972). This was done to quantify the mediation effect of nonsyndromic birth defects alone.…”
Section: Methodsmentioning
confidence: 99%